https://pubmed.ncbi.nlm.nih.gov/31413916/
Daratumumab-225Actinium conjugate demonstrates greatly enhanced antitumor activity against...
Daratumumab is an anti-CD38 directed monoclonal antibody approved for the treatment of multiple myeloma (MM) and functions primarily via Fc-mediated effector...
daratumumabconjugatedemonstratesgreatlyenhanced